SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 5 filers reported holding SQZ BIOTECHNOLOGIES CO in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 1,606,309 | $900 | 0.05% |
| Sandy Cove Advisors, LLC | 51,707 | $28,956 | 0.02% |
| MAVERICK CAPITAL LTD | 1,051,771 | $588,992 | 0.02% |
| Temasek Holdings (Private) Ltd | 2,758,169 | $1,544,575 | 0.01% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,517,173 | $1,409,617 | 0.01% |
| RBF Capital, LLC | 74,674 | $41,817 | 0.00% |
| Laurion Capital Management LP | 431,400 | $241,584 | 0.00% |
| Virtu Financial LLC | 17,075 | $10 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 65,800 | $36,848 | 0.00% |
| Bangor Savings Bank | 11,357 | $6,360 | 0.00% |